CEO
Bio LIMS INC
In 2016, I founded Bio LIMS Inc in the United States, the company focus on the digitalization of genes and biotech, and assisting the digital transformation of life science enterprises. The digital system presided over the research and development has obtained intellectual property rights such as software copyrights and patents in the United States. Obtained a number of international best practice cases in the United States, the Middle East and other places.
I have experience in digital transformation in the fields of precision medicine, biopharmaceutical R&D and production, cell and gene therapy, CRO and CDMO. At present, there are more than 300 biological laboratories, medical institutions, R&D and production enterprises in the world using Bio LIMS INC's digital products.
Currently, my research direction is LLM, AI Agent, GxP digitalization and IIoT (Industrial Internet of Things) application in the life science industry. The company's purpose is to focus on gene and biotechnology informatization, realize smart laboratories and smart manufacturing.